Emerald Advisers, LLC Oyster Point Pharma, Inc. Transaction History

Emerald Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$17.92 - $25.86 $5.23 Million - $7.55 Million	-291,936 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$18.13 - $25.18 $1.05 Million - $1.46 Million	-57,980 Reduced 16.57%	291,936 $5.49 Million
Q3 2020 Oct 28, 2020	BUY	$17.83 - $29.12 $1.17 Million - $1.91 Million	65,431 Added 23.0%	349,916 $7.39 Million
Q2 2020 Jul 28, 2020	BUY	$27.86 - $35.93 $1.6 Million - $2.07 Million	57,604 Added 25.39%	284,485 $8.22 Million
Q1 2020 Apr 30, 2020	SELL	$23.65 - $40.96 $3.48 Million - $6.03 Million	-147,123 Reduced 39.34%	226,881 $7.94 Million
Q4 2019 Jan 29, 2020	BUY	$13.55 - $26.15 $5.07 Million - $9.78 Million	374,004 New	374,004 $9.14 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.